Jacobs & CO Amgen Inc Transaction History

Jacobs & CO

$954 Million
Q2 2024

A detailed history of Jacobs & CO transactions in Amgen Inc stock. As of the latest transaction made, Jacobs & CO holds 44,890 shares of AMGN stock, worth $14.5 Million. This represents 1.47% of its overall portfolio holdings.

Number of Shares

44,890

Previous 45,253 0.8%

Holding current value

$14.5 Million

Previous $12.9 Million 9.02%

% of portfolio

1.47%

Previous 1.36%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 12, 2024	SELL	$262.75 - $319.31 $95,378 - $115,909	-363 Reduced 0.8%	44,890 $14 Million
Q1 2024 Apr 12, 2024	SELL	$268.87 - $324.56 $268 - $324	-1 Reduced -0.0%	45,253 $12.9 Million
Q4 2023 Jan 17, 2024	SELL	$255.7 - $288.46 $188,962 - $213,171	-739 Reduced 1.61%	45,254 $13 Million
Q3 2023 Oct 13, 2023	SELL	$218.65 - $271.46 $195,473 - $242,685	-894 Reduced 1.91%	45,993 $12.4 Million
Q2 2023 Jul 11, 2023	BUY	$214.27 - $253.37 $155,560 - $183,946	726 Added 1.57%	46,887 $10.4 Million
Q1 2023 Apr 17, 2023	BUY	$225.79 - $275.2 $20,095 - $24,492	89 Added 0.19%	46,161 $11.2 Million
Q4 2022 Jan 13, 2023	SELL	$229.03 - $291.01 $164,672 - $209,236	-719 Reduced 1.54%	46,072 $12.1 Million
Q3 2022 Oct 11, 2022	SELL	$224.46 - $253.15 $448 - $506	-2 Reduced -0.0%	46,791 $10.5 Million
Q2 2022 Jul 19, 2022	SELL	$230.71 - $256.74 $201,409 - $224,134	-873 Reduced 1.83%	46,793 $11.4 Million
Q1 2022 Apr 14, 2022	BUY	$219.27 - $242.57 $42,099 - $46,573	192 Added 0.4%	47,666 $11.5 Million
Q4 2021 Jan 21, 2022	BUY	$198.88 - $227.6 $288,773 - $330,475	1,452 Added 3.16%	47,474 $10.7 Million
Q3 2021 Oct 13, 2021	BUY	$212.27 - $248.7 $1.07 Million - $1.26 Million	5,064 Added 12.36%	46,022 $9.79 Million
Q2 2021 Jul 15, 2021	BUY	$233.58 - $259.14 $479,773 - $532,273	2,054 Added 5.28%	40,958 $9.98 Million
Q1 2021 Apr 05, 2021	BUY	$221.91 - $258.6 $64,797 - $75,511	292 Added 0.76%	38,904 $9.68 Million
Q4 2020 Jan 12, 2021	BUY	$216.38 - $257.67 $43,925 - $52,307	203 Added 0.53%	38,612 $8.88 Million
Q3 2020 Dec 03, 2020	SELL	$234.65 - $260.95 $54,438 - $60,540	-232 Reduced 0.6%	38,409 $9.76 Million
Q2 2020 Jul 09, 2020	SELL	$197.81 - $242.74 $284,450 - $349,060	-1,438 Reduced 3.59%	38,641 $9.11 Million
Q1 2020 Apr 13, 2020	BUY	$182.24 - $241.7 $92,031 - $122,058	505 Added 1.28%	40,079 $8.13 Million
Q4 2019 Jan 29, 2020	BUY	$189.21 - $243.2 $123,932 - $159,296	655 Added 1.68%	39,574 $9.54 Million
Q3 2019 Nov 04, 2019	SELL	$174.11 - $208.62 $87,055 - $104,310	-500 Reduced 1.27%	38,919 $7.53 Million
Q2 2019 Aug 01, 2019	BUY	$166.7 - $195.41 $39,007 - $45,725	234 Added 0.6%	39,419 $7.26 Million
Q4 2018 Feb 07, 2019	SELL	$178.4 - $208.25 $119,349 - $139,319	-669 Reduced 1.68%	39,185 $7.63 Million
Q3 2018 Oct 23, 2018	SELL	$185.29 - $208.89 $248,103 - $279,703	-1,339 Reduced 3.25%	39,854 $8.26 Million
Q2 2018 Jul 19, 2018	BUY	$166.05 - $186.51 $239,278 - $268,760	1,441 Added 3.62%	41,193 $7.6 Million
Q1 2018 Apr 30, 2018	BUY	$169.43 - $198.0 $29,650 - $34,650	175 Added 0.44%	39,752 $6.78 Million
Q4 2017 Feb 09, 2018	SELL	$168.79 - $188.59 $111,738 - $124,846	-662 Reduced 1.65%	39,577 $6.84 Million
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $6.73 Million - $7.69 Million	40,239	40,239 $7.5 Million

Others Institutions Holding AMGN

# of Institutions

3,054

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $173B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs & CO with notifications on news.

Account